Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yu Zhang
Institution:
University at Buffalo, State University of New York
Observed institution:
University at Buffalo, State University of New York
ORCID:
0000-0003-3463-9403
Observed ORCID:
0000-0003-3463-9403
OpenAlex ID:
A5047585385
Transient Inhibition of Trastuzumab–Tumor Binding to Overcome the “Binding-Site Barrier” and Improve the Efficacy of a Trastuzumab–Gelonin Immunotoxin
2022
·
Ping Chen
, Brandon M. Bordeau
, et al.
·
Molecular Cancer Therapeutics
·
14
PDF
Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin
2025
·
Ping Chen
, Yu Zhang
, et al.
·
Cancers
PDF
Supplementary Data from Transient Inhibition of Trastuzumab–Tumor Binding to Overcome the “Binding-Site Barrier” and Improve the Efficacy of a Trastuzumab–Gelonin Immunotoxin
2023
·
Ping Chen
, Brandon M. Bordeau
, et al.
Supplementary Data from Transient Inhibition of Trastuzumab–Tumor Binding to Overcome the “Binding-Site Barrier” and Improve the Efficacy of a Trastuzumab–Gelonin Immunotoxin
2023
·
Ping Chen
, Brandon M. Bordeau
, et al.
Supplementary Data from Transient Inhibition of Trastuzumab–Tumor Binding to Overcome the “Binding-Site Barrier” and Improve the Efficacy of a Trastuzumab–Gelonin Immunotoxin
2023
·
Ping Chen
, Brandon M. Bordeau
, et al.
Data from Transient Inhibition of Trastuzumab–Tumor Binding to Overcome the “Binding-Site Barrier” and Improve the Efficacy of a Trastuzumab–Gelonin Immunotoxin
2023
·
Ping Chen
, Brandon M. Bordeau
, et al.
Data from Transient Inhibition of Trastuzumab–Tumor Binding to Overcome the “Binding-Site Barrier” and Improve the Efficacy of a Trastuzumab–Gelonin Immunotoxin
2023
·
Ping Chen
, Brandon M. Bordeau
, et al.
Show more works
View as search
Works count:
7
Citation count:
14
H-index:
1
I10-index:
1
Year
Topic
Type